If you have keloid scars, chances are you’ve struggled with them for a while. These scars are notorious for their ability to resist attempts to treat or remove them, and often regrow a few years later. You have most likely asked yourself how to remove keloid scars a number of times. Here are a few […]
Medgadget Interview With CEO Joe Sardano
Sensus Healthcare’s FDA cleared low energy x-ray technology was the highlight of the discussion when Sensus Healthcare CEO, Joe Sardano, sat down with Medgadget’s Alice Ferng to discuss the benefits of using the SRT-100 and SRT-100 Vision. Click here to view the article.
Simple Daily Habits for Success – Inc.com
Looking to set yourself apart from the crowd in business or in life? Find out what Sensus Healthcare Co-Founder, Chairman and CEO, Joseph Sardano, has to say about it in Christina DesMarais’s article 24 Simple Daily Habits These High Achievers Swear by for Their Success on Inc.com. It’s that simple! “When you manage a results oriented […]
Sensus Healthcare Reports Third Quarter Financial Results Featuring Revenue up 44%
Marks eighth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 2, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the […]
Sensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement with Chindex Medical
BOCA RATON, Fla., Nov. 1, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces it has launched the SRT-100™ in China for the treatment and prevention of keloids with Chindex Medical Limited. Sensus also announces the […]
The Latest Treatment Option for Non-Melanoma Skin Cancers
The Incidence of Non-Melanoma Skin Cancer in the United States Skin cancer is the most common form of cancer in the United States. Did you know it is currently estimated that one in five Americans will develop skin cancer during their lifetime? Nearly 10,000 U.S. citizens are diagnosed every single day. In 2012 alone, it […]
Sensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico
BOCA RATON, Fla., Oct. 31, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ is now cleared for sale in Mexico. The system is approved for the treatment of non-melanoma skin cancer and […]
What is Superficial Radio Therapy? (SRT)
What is Superficial Radio Therapy? Superficial Radio Therapy is the latest non-invasive, non-melanoma skin cancer treatment option. Superficial Radio Therapy is administered with the use of the SRT-100™, our state-of-the-art system inspired by the tried-and-true Superficial Radio Therapy systems that were once the proven gold standard among dermatologists and radiation oncologists. The difference? Our machine […]
Sensus Healthcare to Host Third Quarter 2017 Financial Results and Business Update Conference Call on November 2, 2017
BOCA RATON, Fla., Oct. 25, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announces that management will hold a conference call on Thursday, November 2, 2017 at 4:30 p.m. Eastern time to discuss the financial results for […]
Non-Melanoma Skin Cancer Treatment Market | Analysis and Key Trends 2025
24 OCTOBER 2017 BY MACIEJ HEYMAN Government initiatives to raise awareness of non-melanoma skin cancer Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Government authorities and regulatory bodies are working overtime to educate people about non-melanoma […]
Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radio Therapy & Post-Treatment Care
Collaboration Brings Sensus Healthcare’s SRT Technology and Stratpharma’s Wound Care Medical Devices Together to Advance Radiation Patient Outcomes SAN DIEGO, Oct. 23, 2017 — Stratpharma Inc. USA, a U.S. subsidiary of Stratpharma AG, the Swiss company that specializes in innovative film-forming full-contact topical medical products to improve medical and aesthetic outcomes in post-procedure care in […]
John Berry & Friends All Come Together for Hurricane Relief
John Berry & Friends All Come Together for Hurricane Relief!
Sensus Healthcare to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
BOCA RATON, Fla., Oct. 11, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), today announced that management will present at the Dawson James Securities 3rd Annual Small Cap Growth Conference on Thursday, October 19, 2017 at 12:00 […]
Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announced today that an abstract was presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting, which took place on Oct. 5-8 in […]
Sensus Healthcare Announces Abstract on Treatment of Keloids with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announces that at the American Society for Dermatologic Surgery (ASDS) annual meeting, which took place October 5th-8th in Chicago, an abstract was presented illustrating […]
The Difference Between Basal Cell Carcinoma and Squamous Cell Carcinoma
Basal cell carcinoma and squamous cell carcinoma are the two most common types of skin cancers. According to the American Cancer Society, over 5 million cases of basal cell and squamous cell cancers are diagnosed every year. Though, basal cell carcinoma occurs more often, taking credit for about 80% of these cases. Other than the […]
How to Stop the Recurrence of Keloid Scars with SRT Treatment
Have your patients tried surgical methods of keloid removal, only to find that the keloid scar returns stronger than ever after the operation? Keloid scars are often very difficult to treat, because surgery can send the wrong signals to the skin to restart the wound healing process. This mix-up can lead to a keloid scar […]
Sensus Healthcare to Present at the Ladenburg Thalmann 2017 Healthcare Conference
BOCA RATON, Fla., Sept. 20, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that management will present at the Ladenburg Thalmann Healthcare Conference on Tuesday, September 26, 2017 at 4:00 p.m. Eastern time. The […]
Sensus Healthcare Cancels Presentation to Rodman & Renshaw Global Investment Conference due to Hurricane Irma
BOCA RATON, Fla., Sept. 11, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that management will not be able to present at the Rodman & Renshaw Global Investment Conference due to the impact of […]
Skin Cancer Treatment: No Cutting, No Scarring, No Long Recovery Times
If you are one of the 3.5 million Americans diagnosed with non-melanoma skin cancer, you have a choice. Skin cancer treatment does not have to be a nightmare. With the SRT-100, patients can choose no cutting, no stitching, no scarring and no long recovery times.